GeneGeniusRUO
Services

From a raw VCF or FASTQ to an interpretable, evidence-linked report — in minutes.

We start where sequencing ends. GeneGenius is the interpretation layer in the middle — not the lab, not the clinician — built for the teams turning genomic data into research-ready evidence.

Who we serve

Built for the people who read genomes

Our primary end users are clinicians, diagnostic and sequencing labs, and researchers. We also support genetic counselors, pharmacogenomics specialists, biopharma and translational R&D teams, rare-disease research groups, bioinformatics core facilities, and academic genomics programs.

Analysis dimensions

How we interpret genomic data

Nine signals we combine when interpreting a variant. Not every dimension is independently validated or live yet — treat this as the analysis surface we are building toward, and see the research-use note below.

ACMG/AMP-aligned classification

Variant classification led by core signals (e.g. PVS1, PS1, PM2) rather than a fixed criteria checklist.

Structural & binding impact

Model-predicted binding delta from protein-structure models — a computational signal, not experimental binding energy.

Splicing impact

SpliceAI-based scoring of potential splice disruption around each variant.

Expression outlier

Outlier expression relative to normal tissue, using GTEx baselines for context.

Phenotype-to-gene

Prioritization from synthetic clinical notes and HPO terms. Real-world EHR validation is in progress.

Therapeutic context

Therapeutic research context from CIViC, ClinicalTrials.gov, PharmGKB, and OpenFDA labels — informational, not treatment guidance.

Metabolomic overlay

Pathway-level context layered on findings via KEGG.

Functional rectification

Correcting annotation miscalls to reduce noise carried into interpretation.

Variant-to-mechanism

After the report, mechanism links grounded in the published literature.

Research Use Only

GeneGenius is for research use only (RUO) and is not intended for use in diagnostic procedures or clinical decision-making. Analytical capabilities are under ongoing validation.

See GeneGenius on your own data.

From a raw VCF or FASTQ to an interpretable, evidence-linked research report — in minutes.